NANOG and head and neck squamous cell carcinoma: In the present study, our results suggest that shRNA-mediated knockdown of Nanog can effectively block CSC-like properties and increase the sensitivity of HNSCC-CSCs to cisplatin treatment and induced cell apoptosis.